BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 26, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 21, 1999
View Archived Issues
First human trial of Sheffield's pulmonary delivery system for migraine therapy
Read More
CV Therapeutics receives SBIR grant to study effects of adenosine in angiogenesis
Read More
Bayer to divest Troponwerke division
Read More
German launch and local distributor announced for Tanabe's ACE inhibitor
Read More
SK-951 demonstrates advantages over cisapride in models of impaired gastric emptying
Read More
Positive preliminary results achieved in phase III anti-IgE asthma study
Read More
Licensing opportunity from NIH: orally active neuron cell death-inhibitory peptides
Read More
Schwarz sells intranasal scopolamine rights to Nastech
Read More
Oxford Asymmetry achieves first milestone in collaboration with Ontogeny
Read More
FDA approves topical treatment for nail fungus
Read More
Sankyo to turn joint venture into subsidiary to market products in U.S.
Read More
AstraZeneca discovers new cytokine inhibitors acting as p38 MAP kinase inhibitors
Read More
Inhibitors of PARP activity continue to emerge from Guilford R&D
Read More
Banyu isolates novel antifungal substance BE-54753
Read More
New cardiovascular agents from Yamanouchi
Read More
Efficacy and mechanism of action of DX-9065a in experimental DIC in rats
Read More
Japanese launch announced for Actos; other antidiabetic agents in the pipeline
Read More
Hungarian team describes novel orally active antithrombotic agents
Read More
Parke-Davis identifies atypical antipsychotic with clinical potential
Read More
Orally active antiplatelet agents derived from isoquinolone leads at Lilly
Read More
Discovery of potent FTase inhibitors with excellent cellular and in vivo activity reported by Abbott
Read More
Milestone for Gene Logic in kidney disease collaboration
Read More
Allergan expands ophthalmic allergy product portfolio
Read More
AstraZeneca commences phase II monotherapy trials of ZD-0473
Read More
GRF analogue expected to proceed to phase II trials in 2000
Read More
Neose Technologies discontinues development of NE-1530
Read More
Anti-CD11a enters phase III for psoriasis
Read More
Bristol-Myers Squibb seeks regulatory approvals worldwide for Vanlev
Read More
